The Effect of Alzheimer's Disease on Neurons Across the Sleep/Wake Cycle
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
July 01, 2024 - June 30, 2026
Grant ID
A2024010F
Goals
To determine the activity disruptions in different neuronal subtypes across the sleep/wake cycle in freely behaving APP/PS1 mice, an Alzheimer’s disease mouse model.
Summary
In Alzheimer’s disease, buildup of amyloid beta (Aβ) protein can result in sleep disturbances. Dr. Abedin and his team will investigate the activity of specific neuronal types in a genetically engineered mouse model of Alzheimer’s disease to understand how Aβ affects neuronal activity during the sleep/wake cycle. This research could pave the way for therapeutic development aimed at restoring abnormal neuronal activity and potentially leading to a cure for Alzheimer’s disease.
Unique and Innovative
The conceptual idea of monitoring neuronal activity across the sleep/wake cycle in absence of anesthesia is novel. The proposed research will adopt innovative methodologies to monitor neuronal activity across sleep/wake cycle in freely behaving mice.
Foreseeable Benefits
Alzheimer’s patients suffer from sleep disruptions in addition to memory impairments. Successful completion of the proposed project will provide a solid foundation for future therapeutic development aimed at restoring aberrant neuronal activity during sleep and could lead to a cure for Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
Treating Insomnia in Mild Cognitive Impairment
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Peter Fried, PhD
Treating Insomnia in Mild Cognitive Impairment
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Peter Fried, PhD
Alzheimer's Disease Research
Circadian Rhythm Disruption and Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Ashish Sharma, PhD, MPharm
Circadian Rhythm Disruption and Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Ashish Sharma, PhD, MPharm
Alzheimer's Disease Research
Identifying the Mechanisms That Underlie Tau Aggregation and Neurotoxicity
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Sarah Kaufman, MD, PhD
Identifying the Mechanisms That Underlie Tau Aggregation and Neurotoxicity
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Sarah Kaufman, MD, PhD